story of the week
Low Serum Neurofilament Light Chain Values Identify Optimal Responders to Dimethyl Fumarate in Multiple Sclerosis Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Scientific Reports
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low Serum Neurofilament Light Chain Values Identify Optimal Responders to Dimethyl Fumarate in Multiple Sclerosis Treatment
Sci Rep 2021 Apr 29;[EPub Ahead of Print], PE Walo-Delgado, S Sainz de la Maza, N Villarrubia, E Monreal, S Medina, M Espiño, JI Fernández-Velasco, E Rodríguez-Martín, E Roldán, D Lourido, A Muriel, J Masjuan-Vallejo, L Costa-Frossard, LM VillarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.